Keerthi Kupsal

发表

In silico identification of single nucleotide variations at CpG sites regulating CpG island existence and size

S. R. Hanumanth, N. Shyamala, Chaitra Lava Kongettira, 2022, Scientific Reports.

Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.

R. K. Galimudi, M. S. Kondapalli, S. R. Hanumanth, 2018, Gene.

Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer.

Hanumanth, B. Manavathi, R. K. Galimudi, 2021, Cytokine.

Evaluation of Glycemic, Lipid, Immune-Inflammatory and Oxidative Stress Markers in Various Clinical Stages of Type 2 Diabetic Nephropathy

R. K. Galimudi, S. R. Hanumanth, N. Shyamala, 2018 .

Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer

R. K. Galimudi, M. S. Kondapalli, S. R. Hanumanth, 2017, PloS one.

Glucotoxicity and lipotoxicity induced beta-cell apoptosis in type 2 diabetes mellitus

R. K. Galimudi, S. R. Hanumanth, Keerthi Kupsal, 2015 .

Oxidative Stress Mechanisms in Type 2 Diabetes Induced Coronary Heart Disease

Keerthi Kupsal, S. Hanumanth, 2019, Oxidative Stress in Heart Diseases.

Metformin Combinatorial Therapy for Type 2 Diabetes Mellitus

Keerthi Kupsal, S. Mudigonda, Krishnaveni Neelala, 2016 .

Polymorphic variants of Caspase genes (8 & 3) in the risk prediction of Coronary Artery Disease.

R. K. Galimudi, Padma Gunda, S. Sahu, 2017, Gene.

Association of CYBA gene (-930 A/G and 242 C/T) polymorphisms with oxidative stress in breast cancer: a case-control study

R. K. Galimudi, N. Shyamala, Kaushik Puranam, 2018, PeerJ.

PCSK9 genetic (rs11591147) and epigenetic (DNA methylation) modifications associated with PCSK9 expression and serum proteins in CAD patients

R. K. Galimudi, S. Sahu, N. Shyamala, 2021, The journal of gene medicine.